Pieter Vriesendorp

Pieter Vriesendorp

Interventional cardiologist / Cardiologist
Academic Hospital Maastricht - Maastricht, Netherlands

Latest contributions

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

21 May 2025 – From EuroPCR 2025

This session presents the latest updates on the novel Myval Octapro transcatheter heart valve (THV), based on one year of real-world clinical experience. Experts share practical tips and clinical cases that highlight how this innovative device can improve TAVI patient outcomes. The session also addresses imaging and...

Myval Octapro THV - Optimise patient outcomes with novel design, data and daily clinical practice

Flat-out success: TAVI in a patient with a horizontal aorta and large annulus

16 Oct 2024

Study the case of an 86-year-old male patient with progressive NYHA III dyspnoea, HTN, AF and previous stroke who presented with HF, LVEF 61 %, severe atrial dilatation, severe AS, mild MR and severely calcified tricuspid aortic valve with a large annulus suitable for transfemoral TAVI.

Pieter Vriesendorp

Author

Pieter Vriesendorp
Suzanne Kats

Author

Suzanne Kats

Selection of the 2023 best abstracts

19 Feb 2023 – From PCR Tokyo Valves 2023

Watch this session to discover the best cases and abstracts unveiled at PCR Tokyo Valves 2023, covering topics such as transcatheter aortic valve implantation impact, cerebral protection efficacy, and post-TAVI aortic regurgitation quantification.

Transcatheter edge-to-edge repair for challenging situations

19 Feb 2023 – From PCR Tokyo Valves 2023

Explore various innovative repairs repairs: MitraClip for degenerative regurgitation, TEER bridge therapy, successful combined MitraClip and TriClip procedure, and simultaneous mitral repair with LAA closure.